(268 days)
Not Found
No
The device description and performance studies focus solely on the physical characteristics and mechanical performance of a guidewire, with no mention of software, algorithms, or data processing that would indicate AI/ML.
No.
The device is a guidewire, which facilitates the introduction and placement of other interventional devices within the heart. It does not provide therapy itself.
No
The device is described as an S-Wire Guidewire System, intended to facilitate the introduction and placement of interventional devices inside the heart. It is a tool for device placement, not for diagnosing a condition.
No
The device description clearly details physical components made of nickel-titanium alloy, stainless steel, PTFE, and silicone, and includes a plastic introducer. This indicates it is a hardware device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for facilitating the introduction and placement of interventional devices within the chambers of the heart. This is an in-vivo (within a living organism) procedure, not an in-vitro (outside of a living organism) diagnostic test.
- Device Description: The description details a physical guidewire used for navigation within the body. It does not describe any components or processes related to analyzing biological samples (like blood, urine, or tissue) to diagnose a condition.
- Performance Studies: The performance studies focus on the physical characteristics and integrity of the guidewire itself (tensile strength, shape retention, coating integrity, etc.) and its biocompatibility for use within the body. They do not involve evaluating the device's ability to detect or measure substances in biological samples.
IVD devices are specifically designed to perform tests on samples taken from the human body to provide information for the diagnosis, monitoring, or treatment of diseases or conditions. This device is a tool used during a medical procedure within the body.
N/A
Intended Use / Indications for Use
The S-Wire Guidewire System is intended to facilitate the introduction and placement of interventional devices within the chambers of the heart, including those used in trans-catheter aortic valve implantation (TAVI) procedures.
Product codes (comma separated list FDA assigned to the subject device)
DQX
Device Description
The S-Wire Guidewire System is a sterile, single-use guidewire used for the placement of interventional devices within the aorta and the chambers of the heart. The S-Wire has a 0.035" diameter, and an overall length of 260 cm. The S-Wire construction consists of a nickel-titanium alloy core wire that is PTFE coated, ground and thermally formed. The S-Wire distal coil is made of 304V stainless steel: the distal and proximal ends of the stainless steel coil is bonded to the core wire. The distal portion of the S-Wire has silicone coating. The distal end of the S-Wire has a pre-formed double curve shape consisting of an approximately 360° bend with an outer diameter of approximately 3 cm, and a small S-curve at the distal tip of the wire that is fully contained within the 3 cm curved area. The S-Wire Guidewire System includes a disposable plastic 9 Fr introducer (6 inches long) that is used as an aid in loading the S-Wire into an intravascular catheter.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
chambers of the heart, aorta
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance testing for the Concert Medical S-Wire Guidewire System consists of the measurement of physical characteristics and device integrity in accordance with FDA's Coronary and Cerebrovascular Guidewire Guidance and ISO 11070 (Sterile, single-use intravascular catheter introducers); testing included dimensional inspection, tensile strength (guidewire and introducer), distal loop compression force, distal tip shape retention, tip stiffness, coating integrity, particulate evaluation, catheter compatibility, guidewire flex testing, guidewire fracture testing and corrosion resistance. Where applicable, comparative test results are provided for the S-Wire and the predicate device. Additional testing included in this Premarket Notification includes ISO 10993 biocompatibility testing (cytotoxicity, irritation, sensitization, acute systemic toxicity, hemocompatibility and pyrogen) and sterile package integrity testing (pouch seal tensile strength and dye penetration). The Concert Medical S-Wire Guidewire System met all predetermined acceptance criteria and compared favorably with the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1330 Catheter guide wire.
(a)
Identification. A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.(b)
Classification. Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
0
Image /page/0/Picture/13 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles a caduceus, with three figures in profile facing right.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
August 18, 2016
Concert Medical, LLC % Pamela Papineau President Delphi Medical Device Consulting, Inc. 5 Whitcomb Ave Ayer, Massachusetts 01432
Re: K153397
Trade/Device Name: S-Wire Guidewire System Regulation Number: 21 CFR 870.1330 Regulation Name: Catheter Guide Wire Regulatory Class: Class II Product Code: DOX Dated: November 17, 2015 Received: November 24, 2015
Dear Ms. Papineau:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device
1
related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
M. A. Hilleman
for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K153397
Device Name S-Wire Guidewire System
Indications for Use (Describe)
The S-Wire Guidewire System is intended to facilitate the introduction and placement of interventional devices within the chambers of the heart, including those used in trans-catheter aortic valve implantation (TAVI) procedures.
Type of Use (Select one or both, as applicable)X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary - Revised (Clean Copy)
| Date Prepared: | 15 July 2016 |
|---|---|
| General Information | |
| Owner's Name: | Concert Medical, LLC |
| Address: | 77 Accord Park Drive |
| Norwell, MA 02061 | |
| Telephone: | 781-871-7882 |
| Fax: | 781-724-4555 |
| Contact Person: | Pamela Papineau, RAC (US, EU, CAN) |
| Delphi Medical Device Consulting, Inc. | |
| 5 Whitcomb Avenue | |
| Ayer, MA 01432 | |
| Telephone: | (978) 772-3552 |
| Fax: | (978) 796-5460 |
| Subject Device: | |
| Trade Name: | S-Wire Guidewire System |
| Common Name: | Catheter Guide Wire |
| Product Code: | DQX |
| FDA Regulation: | 21 CFR 870.1330 - Catheter Guide Wire |
| Device Classification: | Class II |
| Predicate Device: | |
| Product Name: | Lake Region Pre-Formed Guidewire (Boston Scientific Safari |
| Pre-Shaped TAVI Guidewire) | |
| Common Name: | Catheter Guide Wire |
| Product Code: | DQX |
| FDA Regulation: | 21 CFR 870.1330 - Catheter Guide Wire |
| Device Classification: | Class II |
| Premarket Notification: | K130798, K151244 |
| Indications for Use |
The S-Wire Guidewire System is intended to facilitate the introduction and placement of interventional devices within the chambers of the heart, including those used in trans-catheter aortic valve implantation (TAVI) procedures
Device Description:
The S-Wire Guidewire System is a sterile, single-use guidewire used for the placement of interventional devices within the aorta and the chambers of the heart. The S-Wire has a 0.035" diameter, and an overall length of 260 cm. The S-Wire construction consists of a nickel-titanium alloy core wire that is PTFE coated, ground and thermally formed. The S-Wire distal coil is
4
made of 304V stainless steel: the distal and proximal ends of the stainless steel coil is bonded to the core wire. The distal portion of the S-Wire has silicone coating. The distal end of the S-Wire has a pre-formed double curve shape consisting of an approximately 360° bend with an outer diameter of approximately 3 cm, and a small S-curve at the distal tip of the wire that is fully contained within the 3 cm curved area. The S-Wire Guidewire System includes a disposable plastic 9 Fr introducer (6 inches long) that is used as an aid in loading the S-Wire into an intravascular catheter.
Substantial Equivalence
The Concert Medical S-Wire Guidewire System is substantially equivalent to the Lake Region Pre-Formed Guidewire (K151244 & K130798), which is marketed by Boston Scientific Corp. as the Safari Pre-Shaped TAVI guidewire. Substantial equivalence, which is summarized below, is based on indications for use, physical and technological characteristics, and comparative device testing.
| | Concert Medical S-Wire Guidewire
System (current submission) | Lake Region Pre-Formed Guidewire
(K151244 & K130798) |
|----------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Device Common/Usual Name | Catheter Guide Wire | Catheter Guide Wire |
| Device Class | Class II | Class II |
| Product Code / Regulation | DQX / 21 CFR 870.1300 | DQX / 21 CFR 870.1300 |
| Regulation Name | Catheter Guide Wire | Catheter Guide Wire |
| Prescription Use | Rx Only | Rx Only |
| Indications for Use | To facilitate the introduction and
placement of interventional devices
within the chambers of the heart,
including those used in trans-catheter
aortic valve implantation (TAVI)
procedures | To facilitate the introduction and
placement of interventional devices
within the chambers of the heart,
including those used within trans-
catheter aortic valve procedures |
| Guidewire OD | 0.035" | 0.035" |
| Guidewire Length | 260 cm | 260 cm – 300 cm |
| Guidewire Materials | Nickel-titanium superelastic alloy,
304V stainless steel, adhesive | A313 stainless steel |
| Guidewire Coating | PTFE (shaft); Silicone (distal coil) | PTFE |
| Tip Shape | Atraumatic double curve | Atraumatic double curve |
| Sterile Device? | Yes | Yes |
| Sterilization Type | Ethylene Oxide | Ethylene Oxide |
| EO Sterilization Residuals | Per ISO 10993-7 | Per ISO 10993-7 |
| Disposable / Reusable | Disposable | Disposable |
Performance Testing:
Performance testing for the Concert Medical S-Wire Guidewire System consists of the measurement of physical characteristics and device integrity in accordance with FDA's Coronary and Cerebrovascular Guidewire Guidance and ISO 11070 (Sterile, single-use intravascular catheter introducers); testing included dimensional inspection, tensile strength (guidewire and introducer), distal loop compression force, distal tip shape retention, tip stiffness, coating integrity, particulate evaluation, catheter compatibility, guidewire flex testing, guidewire fracture testing and corrosion resistance. Where applicable, comparative test results are provided
5
for the S-Wire and the predicate device. Additional testing included in this Premarket Notification includes ISO 10993 biocompatibility testing (cytotoxicity, irritation, sensitization, acute systemic toxicity, hemocompatibility and pyrogen) and sterile package integrity testing (pouch seal tensile strength and dye penetration). The Concert Medical S-Wire Guidewire System met all predetermined acceptance criteria and compared favorably with the predicate device.
Conclusion:
The Concert Medical S-Wire Guidewire System has been demonstrated to be substantially equivalent to the predicate device.